P
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K317.0 KBParatek Pharmaceuticals, Inc.Sep 21, 9:07 AM ET·0001193125-23-239185
- 8-K156.6 KBParatek Pharmaceuticals, Inc.Sep 18, 12:49 PM ET·0001193125-23-236721
- 8-K1.5 MBParatek Pharmaceuticals, Inc.Sep 11, 7:42 AM ET·0001193125-23-231994
- SC 13G139.4 KBParatek Pharmaceuticals, Inc.Sep 5, 5:03 PM ET·0001193805-23-001250
- 10-Q6.3 MBParatek Pharmaceuticals, Inc.Aug 3, 8:31 AM ET·0001628280-23-027035
- 8-K159.7 KBParatek Pharmaceuticals, Inc.Jul 11, 4:10 PM ET·0001193125-23-185332
- SC 13D/A300.6 KBParatek Pharmaceuticals, Inc.Jun 27, 8:20 AM ET·0001193805-23-000894
- 8-K1.0 MBParatek Pharmaceuticals, Inc.Jun 7, 6:07 AM ET·0001193125-23-162024
- 10-Q6.4 MBParatek Pharmaceuticals, Inc.May 9, 4:08 PM ET·0001628280-23-016814
- 10-K/A1.0 MBParatek Pharmaceuticals, Inc.Apr 27, 4:28 PM ET·0001628280-23-013599
Insiders
10- AKKARAJU SRINIVAS10% Owner
- ALBINI EDWARD CV.P., Chief Financial Officer
- Ang IvyV.P., Human Resources
- BARRETT M JAMES10% Owner
- BARRIS PETER J10% Owner
- Baylor-Henry MinnieDirector
- BIGHAM MICHAELDirector, Chairman and CEO
- BLAIR JAMES C10% Owner
- Brenner Randall B.Chief Development & Regulatory
- CASH HARVEY B10% Owner
Tickers
No tickers on record
Addresses
business
75 PARK PLAZA 4TH FLOOR
BOSTON, MA, 02116
mailing
75 PARK PLAZA 4TH FLOOR
BOSTON, MA, 02116
Former Names
- Transcept Pharmaceuticals Inc2014-10-30
- NOVACEA INC2009-01-20